Wand Matthew E, Baker Kate S, Benthall Gabriel, McGregor Hannah, McCowen James W I, Deheer-Graham Ana, Sutton J Mark
Public Health England, Microbiology Services Division, Salisbury, Wiltshire, United Kingdom
Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Antimicrob Agents Chemother. 2015 Jul;59(7):3966-72. doi: 10.1128/AAC.05009-14. Epub 2015 Apr 20.
The EGD Murray collection consists of approximately 500 clinical bacterial isolates, mainly Enterobacteriaceae, isolated from around the world between 1917 and 1949. A number of these "Murray" isolates have subsequently been identified as Klebsiella pneumoniae. Antimicrobial susceptibility testing of these isolates showed that over 30% were resistant to penicillins due to the presence of diverse blaSHV β-lactamase genes. Analysis of susceptibility to skin antiseptics and triclosan showed that while the Murray isolates displayed a range of MIC/minimal bactericidal concentration (MBC) values, the mean MIC value was lower than that for more modern K. pneumoniae isolates tested. All Murray isolates contained the cation efflux gene cepA, which is involved in disinfectant resistance, but those that were more susceptible to chlorhexidine were found to have a 9- or 18-bp insertion in this gene. Susceptibility to other disinfectants, e.g., H2O2, in the Murray isolates was comparable to that in modern K. pneumoniae isolates. The Murray isolates were also less virulent in Galleria and had a different complement of putative virulence factors than the modern isolates, with the exception of an isolate related to the modern lineage CC23. More of the modern isolates (41% compared to 8%) are classified as good/very good biofilm formers, but there was overlap in the two populations. This study demonstrated that a significant proportion of the Murray Klebsiella isolates were resistant to penicillins before their routine use. This collection of pre-antibiotic era isolates may provide significant insights into adaptation in K. pneumoniae in relation to biocide susceptibility.
EGD默里菌库包含约500株临床细菌分离株,主要为肠杆菌科细菌,于1917年至1949年间从世界各地分离得到。其中一些“默里”分离株后来被鉴定为肺炎克雷伯菌。对这些分离株进行的药敏试验表明,由于存在多种blaSHVβ-内酰胺酶基因,超过30%的分离株对青霉素耐药。对皮肤消毒剂和三氯生的敏感性分析表明,虽然默里分离株呈现出一系列的最低抑菌浓度/最低杀菌浓度(MIC/MBC)值,但平均MIC值低于对更现代的肺炎克雷伯菌分离株进行测试的结果。所有默里分离株都含有与消毒剂耐药性有关的阳离子外流基因cepA,但发现对洗必泰更敏感的分离株在该基因中有9或18个碱基对的插入。默里分离株对其他消毒剂(如过氧化氢)的敏感性与现代肺炎克雷伯菌分离株相当。默里分离株在蜡螟中也具有较低的毒力,并且与现代分离株相比,其假定毒力因子的组成不同,但与现代谱系CC23相关的一个分离株除外。更多的现代分离株(4l%,而默里分离株为8%)被归类为良好/非常良好的生物膜形成菌,但两个群体之间存在重叠。这项研究表明,很大一部分默里肺炎克雷伯菌分离株在青霉素常规使用之前就对其耐药。这一抗生素时代之前的分离株库可能为肺炎克雷伯菌在杀菌剂敏感性方面的适应性提供重要见解。